• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无结构 MRI 的淀粉样β和 tau PET 定量。

Quantification of amyloid beta and tau PET without a structural MRI.

机构信息

Helen Wills Neuroscience Institute, University of California Berkeley, Berkeley, California, USA.

Memory and Aging Center, University of California, San Francisco, California, USA.

出版信息

Alzheimers Dement. 2023 Feb;19(2):444-455. doi: 10.1002/alz.12668. Epub 2022 Apr 16.

DOI:10.1002/alz.12668
PMID:35429219
Abstract

INTRODUCTION

Relying on magnetic resonance imaging (MRI) for quantification of positron emission tomography (PET) images may limit generalizability of the results. We evaluated several MRI-free approaches for amyloid beta (Aβ) and tau PET quantification relative to MRI-dependent quantification cross-sectionally and longitudinally.

METHODS

We compared baseline MRI-free and MRI-dependent measurements of Aβ PET ([18F]florbetapir [FBP], N = 1290, [18F]florbetaben [FBB], N = 290) and tau PET ([18F]flortaucipir [FTP], N = 768) images with respect to continuous and dichotomous agreement, effect sizes of Aβ+ impaired versus Aβ- unimpaired groups, and longitudinal standardized uptake value ratio (SUVR) slopes in a subset of individuals.

RESULTS

The best-performing MRI-free approaches had high continuous and dichotomous agreement with MRI-dependent SUVRs for Aβ PET and temporal flortaucipir (R ≥0.95; ± agreement ≥92%) and for Alzheimer's disease-related effect sizes; agreement was slightly lower for entorhinal flortaucipir and longitudinal slopes.

DISCUSSION

There is no consistent loss of baseline or longitudinal AD-related signal with MRI-free Aβ and tau PET image quantification.

摘要

简介

依靠磁共振成像(MRI)对正电子发射断层扫描(PET)图像进行定量可能会限制结果的通用性。我们评估了几种无 MRI 的方法,以横向和纵向比较相对于 MRI 依赖的定量方法对淀粉样蛋白β(Aβ)和 tau PET 的定量。

方法

我们比较了基线无 MRI 和 MRI 依赖的 Aβ PET([18F]florbetapir [FBP],N = 1290,[18F]florbetaben [FBB],N = 290)和 tau PET([18F]flortaucipir [FTP],N = 768)图像的连续和二分类一致性、Aβ+损伤组与 Aβ-未损伤组的效应大小,以及在一部分个体中的纵向标准化摄取值比(SUVR)斜率。

结果

无 MRI 的最佳方法在 Aβ PET 和时间 flortaucipir(R ≥0.95;±一致性≥92%)以及与阿尔茨海默病相关的效应大小方面,与 MRI 依赖的 SUVR 具有高度的连续和二分类一致性;对于内嗅皮质 flortaucipir 和纵向斜率,一致性略低。

讨论

无 MRI 的 Aβ 和 tau PET 图像定量没有明显的基线或纵向 AD 相关信号丢失。

相似文献

1
Quantification of amyloid beta and tau PET without a structural MRI.无结构 MRI 的淀粉样β和 tau PET 定量。
Alzheimers Dement. 2023 Feb;19(2):444-455. doi: 10.1002/alz.12668. Epub 2022 Apr 16.
2
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.Tau 正电子发射断层扫描作为临床前和前驱期阿尔茨海默病预后标志物的准确性:与淀粉样蛋白正电子发射断层扫描和磁共振成像的头对头比较。
JAMA Neurol. 2021 Aug 1;78(8):961-971. doi: 10.1001/jamaneurol.2021.1858.
3
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.基于生物标志物的阿尔茨海默病纵向 Tau 正电子发射断层扫描预测。
JAMA Neurol. 2022 Feb 1;79(2):149-158. doi: 10.1001/jamaneurol.2021.4654.
4
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.氟替卡匹尔PET tau蛋白结合与淀粉样蛋白负荷、临床诊断、年龄和认知之间的关系。
Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.
5
Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment.无认知障碍者初始β-淀粉样蛋白水平与随后氟脱氧葡萄糖正电子发射断层扫描变化的相关性。
JAMA Neurol. 2021 Feb 1;78(2):217-228. doi: 10.1001/jamaneurol.2020.3921.
6
Cross-Sectional and Longitudinal Comparison of Tau Imaging with 18F-MK6240 and 18F-Flortaucipir in Populations Matched for Age, MMSE and Brain Beta-Amyloid Burden.18F-MK6240和18F-氟代tau示踪剂在年龄、简易精神状态检查表(MMSE)和脑β-淀粉样蛋白负荷匹配人群中的tau成像横断面和纵向比较
J Prev Alzheimers Dis. 2023;10(2):251-258. doi: 10.14283/jpad.2023.17.
7
Partial volume correction in longitudinal tau PET studies: is it really needed?纵向tau蛋白正电子发射断层扫描(PET)研究中的部分容积校正:真的有必要吗?
Neuroimage. 2024 Apr 1;289:120537. doi: 10.1016/j.neuroimage.2024.120537. Epub 2024 Feb 15.
8
Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment.比较 Tau PET 视觉解读与 Tau PET 定量、脑脊液生物标志物和纵向临床评估。
J Alzheimers Dis. 2023;93(2):765-777. doi: 10.3233/JAD-230032.
9
18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.18F-Flortaucipir PET 与阿尔茨海默病导致的轻度认知障碍患者的脑脊液、认知和神经影像学的相关性。
J Alzheimers Dis. 2020;74(2):589-601. doi: 10.3233/JAD-191330.
10
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.多中心纵向研究氟替卡滨(18F)在正常衰老、轻度认知障碍和阿尔茨海默病痴呆中的作用。
Brain. 2019 Jun 1;142(6):1723-1735. doi: 10.1093/brain/awz090.

引用本文的文献

1
Reliability of Automated Amyloid PET Quantification: Real-World Validation of Commercial Tools Against Centiloid Project Method.淀粉样蛋白PET自动定量的可靠性:商业工具相对于百分中心项目法的真实世界验证
Tomography. 2025 Jul 30;11(8):86. doi: 10.3390/tomography11080086.
2
MRI-free processing of tau PET images for early detection.用于早期检测的tau正电子发射断层扫描(PET)图像的无磁共振成像(MRI)处理
Imaging Neurosci (Camb). 2024 Nov 13;2. doi: 10.1162/imag_a_00369. eCollection 2024.
3
White Matter Abnormalities and Cognition in Aging and Alzheimer Disease.
衰老与阿尔茨海默病中的白质异常与认知
JAMA Neurol. 2025 Jun 9. doi: 10.1001/jamaneurol.2025.1601.
4
Amyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort.淀粉样蛋白正电子发射断层扫描可预测异质性队列中的纵向功能和认知轨迹。
Alzheimers Dement. 2025 Mar;21(3):e70075. doi: 10.1002/alz.70075.
5
A practical overview of the use of amyloid-PET Centiloid values in clinical trials and research.淀粉样蛋白PET百分标准值在临床试验和研究中的实际应用概述。
Neuroimage Clin. 2025 Mar 10;46:103765. doi: 10.1016/j.nicl.2025.103765.
6
Associations of Cerebrospinal Fluid Orexin-A, Alzheimer Disease Biomarkers, and Cognitive Performance.脑脊液中食欲素-A、阿尔茨海默病生物标志物与认知表现的关联
Ann Clin Transl Neurol. 2025 Apr;12(4):780-791. doi: 10.1002/acn3.70009. Epub 2025 Feb 17.
7
The POINTER Imaging baseline cohort: Associations between multimodal neuroimaging biomarkers, cardiovascular health, and cognition.POINTER影像基线队列:多模态神经影像生物标志物、心血管健康与认知之间的关联。
Alzheimers Dement. 2025 Jan;21(1):e14399. doi: 10.1002/alz.14399. Epub 2024 Dec 6.
8
The Consortium for Clarity in ADRD Research Through Imaging (CLARiTI).通过成像提高ADRD研究清晰度联盟(CLARiTI)
Alzheimers Dement. 2025 Jan;21(1):e14383. doi: 10.1002/alz.14383. Epub 2024 Nov 26.
9
Positron emission tomography harmonization in the Alzheimer's Disease Neuroimaging Initiative: A scalable and rigorous approach to multisite amyloid and tau quantification.阿尔茨海默病神经影像倡议中的正电子发射断层扫描标准化:一种用于多站点淀粉样蛋白和tau蛋白定量的可扩展且严谨的方法。
Alzheimers Dement. 2025 Jan;21(1):e14378. doi: 10.1002/alz.14378. Epub 2024 Nov 19.
10
Relationships between abdominal adipose tissue and neuroinflammation with diffusion basis spectrum imaging in midlife obesity.中年肥胖人群中腹部脂肪组织与神经炎症在扩散基谱成像上的关系
Obesity (Silver Spring). 2025 Jan;33(1):41-53. doi: 10.1002/oby.24188. Epub 2024 Nov 8.